Research Article
Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice
Figure 7
Eradication with bismuth quadruple therapy based on previous exposure to a metronidazole-containing H. pylori treatment. Risk difference: 10% (PP, 95% CI: −2–25) and 8% (ITT, 95% CI: −5–25).